CDC panel meets Tuesday to vote on COVID-19 vaccine priority
ATLANTA (AP) — A panel of U.S. advisers will meet Tuesday to vote on how scarce, initial supplies of a COVID-19 vaccine will be given out once one has been approved.
Experts have proposed giving the vaccine to health workers first. High priority also may be given to workers in essential industries, people with certain medical conditions and people age 65 and older.
Tuesday's meeting is for the Advisory Committee on Immunization Practices, a group established by the Centers for Disease Control and Prevention. The panel of experts recommends who to vaccinate and when -- advice that the government almost always follows. The agenda for next week's emergency meeting was posted Friday.
Pfizer and its German partner BioNTech have asked the Food and Drug Administration to allow emergency use of its COVID-19 vaccine candidate. Moderna Inc. is expected to also seek emergency use of its vaccine soon.
FDA's scientific advisers are holding a public meeting Dec. 10 to review Pfizer's request, and send a recommendation to the FDA.
Manufacturers already have begun stockpiling coronavirus vaccine doses in anticipation of eventual approval, but the first shots will be in short supply and rationed.
Stories that may interest you
A group that counts political detentions says Russian police have arrested more than 3,000 protesters who took to the streets across the country in temperatures as low as minus-50 C (minus-58 F) to demand the release of Alexei Navalny, the Kremlin's most prominent foe
Federal law enforcement officials are privately debating whether they should decline to charge some of the individuals who stormed the U.S. Capitol this month - a politically loaded proposition but one alert to the practical concern that hundreds of such cases could swamp the local courthouse.
The United States appears to have avoided the worst-case coronavirus scenarios that officials feared would overwhelm hospitals in the aftermath of Christmas and New Year's gatherings. But experts caution that the threat from the virus has not diminished and could intensify with the emergence of new...
All of our stories about the coronavirus are being provided free of charge as a service to the public. You can find all of our stories here.
You can support local journalism by subscribing to The Day.